Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 7.09% vs 0.55% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 984.41% vs -109.44% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 20.01% vs -14.65% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 48.70% vs -22.42% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Takeda Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 7.09% vs 0.55% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 4.16% vs 2.96% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 984.41% vs -109.44% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 335.21% vs -77.46% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 20.01% vs -14.65% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 12.63% vs 2.93% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is 48.70% vs -22.42% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 291.27% vs -53.07% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






